Introduction of Simplification - Jordan Feld, MD, MPH

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Introduction of Simplification- Jordan Feld, MD, MPH

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

WHO / Perspective on the Simplification Strategies- Philippa Easterbrook, MD, FRCP, MPH, DTM&H

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

WHA / Community Perspective on the Need for Simplification- Michael Ninburg

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Canada’s Experience with Needle Exchange Programs- Mark Tyndall, MD, ScD, FRCPC

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Monitoring and Testing, Introductory Lecture- Manal El-Sayed, MD, PhD

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Uganda’s Experience- Kenneth Kabagambe

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Use of the HBV Viral Load Medical Prescription as a Preliminary Assessment of HBV Infection Burden in New Caledonia: a 2014-2019 Retrospective Study- P. Dény

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Mortality from Liver Diseases Associated with Hepatitis B and C in the EU/EEA – Descriptive Analysis and Estimation of 2015 Baseline- O. Mårdh

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

The Uptake of an Innovative Approach to Reduce HCV Transmission among MSM: the NoMoreC Project- T. Prinsenberg

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Model for Care - Focus on HBV, Introductory Lecture- Jordan Feld, MD, MPH

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Emergency Department Screening: Strategy for Elimination through an Innovative HBV and HCV Screening, Care, and Cure Program- S. Wang

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Rwanda’s Model for Care- Jean Damascene Makuza, MD

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Changes of the Composition of the Hepatitis B Virus (HBV) surface Antigen (HBsAg) are Associated with HBsAg Loss during Nucleos(tid)e Analogues and Peg-interferon-alfa2a Treatment- M. Pfefferkorn

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Model for Care - Focus on HCV, Introductory Lecture- Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Pakistan’s Model for Care- Huma Qureshi, MD

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Evaluation of the Hepatitis C Care Cascade in the Country of Georgia: Monitoring Progress towards Elimination- T. Tsertsvadze

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Strategies towards Elimination of Hepatitis C in Iceland: Models of Care for the Treatment as Prevention for Hepatitis C (TraP HeP C) Program- M. Gottfredsson

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Micro-Elimination of Hepatitis C amongst People Living with HIV (PLHIV) in Punjab, India- P. Katapur

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Integration of Hepatitis C Treatment Services with Harm Reduction Service Centers for People who Inject Drugs in Kenya: Experience from Test and Link to Care for Injecting Drug Users Study- M. Nyakowa

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Towards the Elimination of HCV in British Columbia: A strategy to Address the “messy middle”- B. Conway

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Real-World Challenges to and Opportunities for Microelimination in Two Remote Communities in Northwestern Ontario- D. Smookler

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Policy Implementation Index Based off of Patient Reported Outcomes: The Hep-CORE Study- A. Palayew

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

Mongolia’s Model for Care- Naranjargal Dashdorj, MD, PhD

International Viral Hepatitis Elimination Meeting (IVHEM) 2019